<!DOCTYPE HTML SYSTEM "HTML4.DTD" >
<HTML>
<HEAD>
<TITLE>ICD-10: Block C81-C96
</TITLE>
<LINK HREF="style.css" REL="stylesheet" TYPE="text/css">
<META NAME="AUTHOR" CONTENT="Michael Schopen">
<META NAME="DESCRIPTION" CONTENT="International Statistical Classification of Diseases and Related Health Problems (ICD-10). HTML files for WWW.">
<META NAME="KEYWORDS" CONTENT="ICD-10; tabular list;chapter II">
<META NAME="COPYRIGHT" CONTENT="WHO">
<META NAME="ROBOTS" CONTENT="index, follow">
<SCRIPT TYPE="text/JavaScript">
  function openSub(URL) {
    var SUB = window.open(URL, "SUB", "dependent=1,height=200,width=500,resizable=1,scrollbars=1") ;
    SUB.focus() ;
  }
</SCRIPT>
<SCRIPT TYPE="text/JavaScript">
function setNavi(url,hash) {
  if (window.name != "SUB") {
    if ((parent.location.href == self.location.href) || (!parent.correct_frame)) {
      window.location.replace('fr-icd.htm?'+url+'+'+hash) ;
    }
    else {
      with (parent.navi.document) {
        open('text/html','replace') ;
        writeln('<HEAD>') ;
        writeln('<TITLE>Navigational frame work ICD-10</TITLE>') ;
        writeln('<link href="style.css" rel="stylesheet" type="text/css">') ;
        writeln('</HEAD>') ;
        writeln('<BODY BGCOLOR="#000080">') ;
        writeln('<table border="0" cellpadding="4" cellspacing="4" width="100%">') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="navi.htm#ka00">List&nbsp;of&nbsp;Chapters</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="kc00.htm">Chapter&nbsp;Introduction</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="kc00.htm#glied">List&nbsp;of&nbsp;Blocks</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="gc76.htm">Previous&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="gc97.htm">Next&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td>&nbsp;</td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="_top" HREF="http://www.who.int/classifications/icd">ICD Homepage</A></td></tr></table>') ;
        close() ;
      }
    }
  }
}
</SCRIPT>

</HEAD>

<BODY BGCOLOR="#FFFFFF" onLoad="setNavi('gc81.htm',window.location.hash.substring(1))">

<H1>Chapter II
<BR>
<HR>Neoplasms
<BR>(C00-D48)
</H1>

<H2>Malignant neoplasms

<BR>(C00-C97)

</H2>
<H3>Malignant neoplasms of lymphoid, haematopoietic and related tissue
<BR>(C81-C96)
</H3>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Note:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">The terms used in categories C82-C85 for non-Hodgkin's lymphomas are those of the Working Formulation, which attempted to find common ground among several major classification schemes. The terms used in these schemes are not given in the Tabular List but appear in the Alphabetical Index; exact equivalence with the terms appearing in the Tabular List is not always possible.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">morphology codes M959-M994 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">secondary and unspecified neoplasm of lymph nodes 
<NOBR>(
<A HREF="gc76.htm#c77">C77.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c81">
</A>C81
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hodgkin's disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M965-M966 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c810">
</A>C81.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphocytic predominance
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Lymphocytic-histiocytic predominance
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c811">
</A>C81.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Nodular sclerosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c812">
</A>C81.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mixed cellularity
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c813">
</A>C81.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphocytic depletion
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c817">
</A>C81.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other Hodgkin's disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c819">
</A>C81.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hodgkin's disease, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c82">
</A>C82
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Follicular [nodular] non-Hodgkin's lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">follicular non-Hodgkin's lymphoma with or without diffuse areas
<BR>morphology code M969 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c820">
</A>C82.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Small cleaved cell, follicular
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c821">
</A>C82.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mixed small cleaved and large cell, follicular
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c822">
</A>C82.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Large cell, follicular
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c827">
</A>C82.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other types of follicular non-Hodgkin's lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c829">
</A>C82.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Follicular non-Hodgkin's lymphoma, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Nodular non-Hodgkin's lymphoma NOS
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c83">
</A>C83
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Diffuse non-Hodgkin's lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M9593, M9595, M967-M968 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c830">
</A>C83.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Small cell (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c831">
</A>C83.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Small cleaved cell (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c832">
</A>C83.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mixed small and large cell (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c833">
</A>C83.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Large cell (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Reticulum cell sarcoma
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c834">
</A>C83.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Immunoblastic (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c835">
</A>C83.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphoblastic (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c836">
</A>C83.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Undifferentiated (diffuse)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c837">
</A>C83.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Burkitt's tumour
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c838">
</A>C83.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other types of diffuse non-Hodgkin's lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c839">
</A>C83.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Diffuse non-Hodgkin's lymphoma, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c84">
</A>C84
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Peripheral and cutaneous T-cell lymphomas
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology code M970 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c840">
</A>C84.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mycosis fungoides
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c841">
</A>C84.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>S&eacute;zary's disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c842">
</A>C84.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>T-zone lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c843">
</A>C84.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphoepithelioid lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Lennert's lymphoma
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c844">
</A>C84.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Peripheral T-cell lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c845">
</A>C84.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified T-cell lymphomas
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Note:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">If T-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c85">
</A>C85
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified types of non-Hodgkin's lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M9590-M9592, M9594, M971 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c850">
</A>C85.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphosarcoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c851">
</A>C85.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>B-cell lymphoma, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Note:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">If B-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c857">
</A>C85.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified types of non-Hodgkin's lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Malignant:
<BR>&middot; reticuloendotheliosis
<BR>&middot; reticulosis
<BR>Microglioma
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c859">
</A>C85.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Non-Hodgkin's lymphoma, unspecified type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Lymphoma NOS
<BR>Malignant lymphoma NOS
<BR>Non-Hodgkin's lymphoma NOS
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c88">
</A>C88
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Malignant immunoproliferative diseases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology code M976 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c880">
</A>C88.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Waldenstr&ouml;m's macroglobulinaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c881">
</A>C88.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Alpha heavy chain disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c882">
</A>C88.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Gamma heavy chain disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Franklin's disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c883">
</A>C88.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Immunoproliferative small intestinal disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Mediterranean disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c887">
</A>C88.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other malignant immunoproliferative diseases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c889">
</A>C88.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Malignant immunoproliferative disease, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Immunoproliferative disease NOS
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c90">
</A>C90
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Multiple myeloma and malignant plasma cell neoplasms
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M973, M9830 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c900">
</A>C90.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Multiple myeloma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Kahler's disease
<BR>Myelomatosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">solitary myeloma 
<NOBR>(
<A HREF="#c902">C90.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c901">
</A>C90.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Plasma cell leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c902">
</A>C90.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Plasmacytoma, extramedullary
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Malignant plasma cell tumour NOS
<BR>Plasmacytoma NOS
<BR>Solitary myeloma
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c91">
</A>C91
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphoid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M982, M9940-M9941 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c910">
</A>C91.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute lymphoblastic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">acute exacerbation of chronic lymphocytic leukaemia 
<NOBR>(
<A HREF="#c911">C91.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c911">
</A>C91.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Chronic lymphocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c912">
</A>C91.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Subacute lymphocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c913">
</A>C91.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Prolymphocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c914">
</A>C91.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hairy-cell leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Leukaemic reticuloendotheliosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c915">
</A>C91.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Adult T-cell leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c917">
</A>C91.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other lymphoid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c919">
</A>C91.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lymphoid leukaemia, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c92">
</A>C92
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myeloid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">leukaemia:
<BR>&middot; granulocytic
<BR>&middot; myelogenous
<BR>morphology codes M986-M988, M9930 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c920">
</A>C92.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute myeloid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">acute exacerbation of chronic myeloid leukaemia 
<NOBR>(
<A HREF="#c921">C92.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c921">
</A>C92.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Chronic myeloid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c922">
</A>C92.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Subacute myeloid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c923">
</A>C92.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myeloid sarcoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Chloroma
<BR>Granulocytic sarcoma
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c924">
</A>C92.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute promyelocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c925">
</A>C92.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute myelomonocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c927">
</A>C92.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other myeloid leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c929">
</A>C92.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myeloid leukaemia, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c93">
</A>C93
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Monocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">monocytoid leukaemia
<BR>morphology code M989 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c930">
</A>C93.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute monocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">acute exacerbation of chronic monocytic leukaemia 
<NOBR>(
<A HREF="#c931">C93.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c931">
</A>C93.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Chronic monocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c932">
</A>C93.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Subacute monocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c937">
</A>C93.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other monocytic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c939">
</A>C93.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Monocytic leukaemia, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c94">
</A>C94
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other leukaemias of specified cell type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M984, M9850, M9900, M9910, M9931-M9932 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">leukaemic reticuloendotheliosis 
<NOBR>(
<A HREF="#c914">C91.4
</A>)
</NOBR>
<BR>plasma cell leukaemia 
<NOBR>(
<A HREF="#c901">C90.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c940">
</A>C94.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute erythraemia and erythroleukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acute erythraemic myelosis
<BR>Di Guglielmo's disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c941">
</A>C94.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Chronic erythraemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Heilmeyer-Sch&ouml;ner disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c942">
</A>C94.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute megakaryoblastic leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Leukaemia:
<BR>&middot; megakaryoblastic (acute)
<BR>&middot; megakaryocytic (acute)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c943">
</A>C94.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mast cell leukaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c944">
</A>C94.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute panmyelosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c945">
</A>C94.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute myelofibrosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c947">
</A>C94.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified leukaemias
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Lymphosarcoma cell leukaemia
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c95">
</A>C95
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Leukaemia of unspecified cell type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology code M980 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c950">
</A>C95.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acute leukaemia of unspecified cell type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Blast cell leukaemia
<BR>Stem cell leukaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">acute exacerbation of unspecified chronic leukaemia 
<NOBR>(
<A HREF="#c951">C95.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c951">
</A>C95.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Chronic leukaemia of unspecified cell type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c952">
</A>C95.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Subacute leukaemia of unspecified cell type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c957">
</A>C95.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other leukaemia of unspecified cell type
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c959">
</A>C95.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Leukaemia, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="c96">
</A>C96
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">morphology codes M972, M974 with behaviour code /3
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c960">
</A>C96.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Letterer-Siwe disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Nonlipid:
<BR>&middot; reticuloendotheliosis
<BR>&middot; reticulosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c961">
</A>C96.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Malignant histiocytosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Histiocytic medullary reticulosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c962">
</A>C96.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Malignant mast cell tumour
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Malignant:
<BR>&middot; mastocytoma
<BR>&middot; mastocytosis
<BR>Mast cell sarcoma
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">mast cell leukaemia 
<NOBR>(
<A HREF="#c943">C94.3
</A>)
</NOBR>
<BR>mastocytosis (cutaneous) 
<NOBR>(
<A HREF="gq80.htm#q822">Q82.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c963">
</A>C96.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>True histiocytic lymphoma
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c967">
</A>C96.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="c969">
</A>C96.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<HR>
<TABLE BORDER="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="33%">Processed on 03.06.2003 
<A HREF="mailto:schopen@dimdi.de">M.S.
</A>
</TD>
<TD VALIGN="TOP" ALIGN="CENTER" WIDTH="34%">Source: World Health Organization
</TD>
<TD VALIGN="TOP" ALIGN="RIGHT" WIDTH="33%">&copy; Copyright WHO 1994/2003
</TD>
</TR>
</TABLE>

</BODY >

</HTML>
